Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
Seda Kahraman,1 Suayib Yalcin2 1Yıldırım Beyazıt University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; 2Hacettepe University Institute of Cancer, Department of Medical Oncology, Ankara, TurkeyCorrespondence: Suayib YalcinHacettepe...
Main Authors: | Kahraman S, Yalcin S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/recent-advances-in-systemic-treatments-for-her-2-positive-advanced-gas-peer-reviewed-fulltext-article-OTT |
Similar Items
-
The effect of combinated treatment of a metastatic HER2-positive stomach cancer
by: R A Khvastunov, et al.
Published: (2014-12-01) -
Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?
by: Angela Dalia Ricci, et al.
Published: (2021-04-01) -
Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer
by: Fu XM, et al.
Published: (2018-09-01) -
Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study
by: Tong G, et al.
Published: (2020-04-01) -
Sustained Clinical Benefit of Pyrotinib Combined with Capecitabine Rescue Therapy After Trastuzumab Resistance in HER2-Positive Advanced Gastric Cancer: A Case Report
by: Li X, et al.
Published: (2021-07-01)